TriSalus Life Sciences (TLSIW) Assets (2020 - 2026)

TriSalus Life Sciences has reported Assets for 7 years, with the latest figure at $71.0 million in Q1 2026.

• For the quarter ending Q1 2026, Assets rose 147.96% year-over-year to $71.0 million; the trailing twelve-month figure through Mar 2026 stood at $71.0 million (up 147.96% YoY), and the FY2025 full-year result was $35.3 million, up 47.39% from the prior year.
• Assets for Q1 2026 stood at $71.0 million, up from $35.3 million in the prior quarter.
• The five-year high for Assets was $251.3 million in Q3 2022, with the low at $12.2 million in Q2 2023.
• Historically, Assets has averaged $69.4 million across 5 years, with a median of $32.4 million in 2024.
• Annual changes were most pronounced in 2023 — Assets plunged 95.12% — and 2024, when it jumped 165.01%.
• TriSalus Life Sciences' Assets stood at $22.0 million in 2022, then grew by 11.83% to $24.6 million in 2023, then declined by 2.55% to $24.0 million in 2024, then surged by 47.39% to $35.3 million in 2025, then soared by 100.9% to $71.0 million in 2026.
• The last three Assets figures came in at $71.0 million (Q1 2026), $35.3 million (Q4 2025), and $36.5 million (Q3 2025), per Business Quant data.